MG1-HPV

FDA Accepts Turnstone Biologics' IND for Immunotherapy Targeting HPV Positive Cancers
CP Wire
Wed, 05/16/18 - 09:47 am
Turnstone Biologics
MG1
immunotherapy
MG1-HPV